newsfilter
← Latest News
Business Wire·

Delcath Systems Reports Second Quarter 2026 Results and Business Highlights

Increases 2026 Revenue Guidance to a Range of $104M to $108M Conference Call Today at 8:30 a.m. Eastern Time Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary